Condition : Osteoarthritis of Subtalar Joint Intervention : Biological: Platelet Rich Plasma Sponsor : Meir Medical Center Not yet recruiting - verified August 2011

Condition : Rheumatoid Arthritis Interventions : Drug: 50 mg LX3305 QD; Drug: 100 mg LX3305 QD; Drug: 150 mg LX3305 QD; Drug: 200 mg LX3305 QD; Drug: 250 mg LX3305 QD; Drug: 300 mg LX3305 QD; Drug: 40...

Conditions : Osteoarthritis; Avascular Necrosis; Rheumatoid Arthritis; Congenital Dysplasia of the Hip; Ankylosing Spondylitis; Post-traumatic; Arthrosis; Injury of Hip and Thigh Interventions : Devic...

Condition : Acute Rheumatoid Arthritis Intervention : Drug: s.c. injections of bovine intestinal Alkaline Phosphatase Sponsors : Alloksys Life Sciences B.V.; Aix Scientifics Recruiting - verified Augu...

The purpose of this study is to determine whether arhalofenate is safe and effective when dosed in combination with febuxostat in lowering serum uric acid in patients with gout.

Condition : Ankylosing Spondylitis Intervention : Biological: Human umbilical cord-derived MSCs Sponsor : Shandong University Recruiting - verified April 2011

Condition : Lumbar Spine Degeneration Interventions : Device: INFUSE Bone Graft; Other: Iliac Crest Bone Graft Sponsor : Medtronic Spinal and Biologics Suspended - verified February 2014

Condition : Lumbar Spine Degeneration Interventions : Device: INFUSE Bone Graft; Other: Iliac Crest Bone Graft Sponsor : Medtronic Spinal and Biologics Not yet recruiting - verified August 2011

Condition : Osteoarthritis Interventions : Device: Active Device (Torino II); Device: Sham Device (Torino II) Sponsor : Center for Joint Surgery and Sports Medicine, Maryland Recruiting - verified Aug...

Condition : Lumbar Spine Degeneration Interventions : Device: INFUSE Bone Graft; Other: Iliac Crest Bone Graft Sponsor : Medtronic Spinal and Biologics Not yet recruiting - verified August 2011